MARKET NEWS

 

Cambrex Completes Biopharmaceutical Expansion at its Durham Facility
Roquette Launches Online Technical Platform for Researchers & Drug Developers
Cytovia Therapeutics & Macromoltek to Develop Dual-Acting Natural Killer Immunotherapy Against SARS CoV2 (COVID-19)
Global Regulators Discuss Observational Studies of Real-World Data for COVID-19 Medicines
Emisphere Announces Novo Nordisk Development Update
Antiviral Drugs Market to Foresee Tremendous Gains Over 2020-2026
Metrion Biosciences & International Scientific Consortium Publish Data & New Recommendations for In Vitro Risk Assessment of the Cardiac Safety of New Medicines
Proveris to Present: The Effect of Ethanol Concentration on pMDI Evaporation Fraction

  FEATURED EDITORIAL

  COMPANY PROFILE

Backed by over 85 years of experience in parenterals, Baxter’s BioPharma Solutions (BPS) business collaborates with pharmaceutical companies to support commercialization objectives for their molecules. BPS is a premier CMO with a focus on injectable pharmaceutical manufacturing designed to meet complex and traditional sterile manufacturing challenges with confidence of delivery, service, and integrity. BPS can support your pharmaceutical needs with a broad portfolio of sterile fill/finish production capabilities, and our reputation is built on the high-quality products we manufacture for our clients in a cGMP environment. Click here for more.

  EXCLUSIVE ONLINE CONTENT

Precision BioSciences Announces Dosing of First Patient in Phase 1/2a Clinical Trial

Precision BioSciences Announces Dosing of First Patient in Phase 1/2a Clinical Trial

Precision BioSciences, Inc. recently announced the initiation of patient dosing in a Phase 1/2a clinical trial of its second off-the-shelf (allogeneic) chimeric….

OncoSec Collaborates With Providence Cancer Institute to Conduct First-in-Human Trial of Investigational Vaccine to Prevent COVID-19

OncoSec Collaborates With Providence Cancer Institute to Conduct First-in-Human Trial of Investigational Vaccine to Prevent COVID-19

OncoSec Medical Incorporated recently announced that Providence Cancer Institute, a part of Providence St. Joseph Health, is pursuing a first-in-human Phase 1 clinical trial of OncoSec’s novel….

Leading BioSciences Announces Potential for Investigational Drug to Treat Multiple Organ Dysfunction Syndrome in COVID-19 Patients

Leading BioSciences Announces Potential for Investigational Drug to Treat Multiple Organ Dysfunction Syndrome in COVID-19 Patients

Leading BioSciences recently announced it has developed a potential approach to treat COVID-19 patients suffering from acute respiratory distress syndrome (ARDS) and multiple organ dysfunction syndrome (MODS) using its….

Beam Therapeutics Licenses SIRION Biotech’s LentiBOOST Technology

Beam Therapeutics Licenses SIRION Biotech’s LentiBOOST Technology

SIRION Biotech GmbH recently announced that Beam Therapeutics licensed rights to use SIRION Biotech’s LentiBOOST for use in….

COVID-19 Therapeutics: Summary of Recently Published Clinical Study using Hydroxychloroquine

COVID-19 Therapeutics: Summary of Recently Published Clinical Study using Hydroxychloroquine

Hydroxychloroquine sulphate (Plaquenil) an analog of chloroquine has an established track record for treating malaria and has demonstrated in vitro activity against the SARS-CoV and therefore …..

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

April 22 – Inhalation Drug Delivery
April 29 – Formulation Develoment